GI Disease Is Most Common Diagnosis for Nonmigrant U.S. Travelers
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, June 28, 2023 -- Of U.S. travelers with confirmed or probable travel-related diagnoses, the majority are nonmigrant travelers, who most often receive a gastrointestinal disease diagnosis, according to research published in the June 30 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ashley B. Brown, M.P.H., from the CDC in Atlanta, and colleagues summarized data from 20 U.S. GeoSentinel sites, which monitor infectious diseases and other adverse health events that affect international travelers. During a 10-year surveillance period (2012 to 2021), data were submitted on 18,336 patients, of whom 17,389 lived in the United States; 43.3 and 56.7 percent, respectively, were recent migrants to the United States and returning nonmigrant travelers.
The researchers found that of the 13,968 diagnoses among migrants, vitamin D deficiency, Blastocystis, and latent tuberculosis were the most frequent diagnoses (20.2, 10.9, and 10.3 percent, respectively); less than 1 percent were diagnosed with malaria. Among nonmigrant travelers, the most frequent of the 11,987 diagnoses were related to the gastrointestinal system (43.2 percent), with acute diarrhea, viral syndrome, and irritable bowel syndrome being the most frequent diagnoses (16.9, 4.9, and 4.1 percent); malaria was diagnosed in 3.5 percent of nonmigrant travelers.
"The findings in this report describe the scope of health-related conditions that migrants and returning nonmigrant travelers to the United States acquired, illustrating risk for acquiring illnesses during travel," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted June 2023
Read this next
Ingestion Hazard Prompts Recall of Small Magnetic Balls
FRIDAY, Dec. 29, 2023 -- Citing thousands of hospitalizations and at least seven deaths linked to high-powered magnetic balls, the U.S. Consumer Product Safety Commission...
pH-Multichannel Intraluminal Impedance Monitoring Can ID GERD
FRIDAY, Dec. 29, 2023 -- For preschool-aged children, pH-multichannel intraluminal impedance (MII) monitoring is useful for diagnosing gastroesophageal reflux disease...
Retrograde Cricopharyngeus Dysfunction Often Not Discussed With PCPs
WEDNESDAY, Dec. 20, 2023 -- Patients with retrograde cricopharyngeus dysfunction (R-CPD), which refers to the cricopharyngeal muscle's inability to relax to allow the retrograde...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.